Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Turn Therapeutics Inc's Competitiveness

Name: Turn Therapeutics Inc Competitors and Peer Comparison
Creator: CSIMarket
License: https://csimarket.com/help/terms-of-use

A competitive positioning analysis and financial ratio benchmarking of Turn Therapeutics Inc (TTRX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q1 2026

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/TTRX/competitors                    

                        https://api.csimarket.com/api/v1/companies/TTRX/relationships                    

                        https://api.csimarket.com/api/v1/companies/TTRX/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

Turn Therapeutics Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity	Profitable	Expanding	Above Industry Growth	Distressed
Turn Therapeutics Inc	-	-	-	Yes
Similar-Size Competitors (10)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

TTRX Stock Performance relative to its Competitors

TTRX Competitors (weighted) Percent change over the selected range

Turn Therapeutics Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.

Similar-Size
(3 of 10)

Entity	TTM Share Price Return (group: median)	vs U.S.A. 500
Turn Therapeutics Inc	-	-
Competitors combined (0)	40.4%	63.2%
High-Confidence Competitors (0)	40.4%	63.2%
Similar-Size Competitors (10)	40.4%	63.2%
Similar Growth & Profitability (0)	40.4%	63.2%

Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Turn Therapeutics Inc's competitor groups requires a Commercial License.

Unlock Commercial Access

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

TTRX Stock Performance relative to High-Confidence Competitors

TTRX High-Confidence Competitors (equal-weighted, 1) Percent change over the selected range

TTRX Stock Performance relative to Similar-Size Competitors

TTRX Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

Turn Therapeutics Inc's Comment on Competition and Industry Peers

The biopharmaceutical industry is characterized by intense competition and rapid technological advancements, with a strong emphasis on intellectual property and proprietary products. Competitors include major biopharmaceutical companies, academic institutions, government agencies, and both public and private research institutions. Many competitors possess greater financial resources and more advanced stages of product development. Smaller or early-stage companies can also be significant competitors, particularly through collaborations with larger companies. Competitors may develop similar technologies using different approaches, and patent protections may be subject to challenges or limitations, impacting competitive advantages.

Competitor data is not yet available for Turn Therapeutics Inc.

Turn Therapeutics Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.

Competitor	Basis	Confidence	Active	Sources
AOL Inc.	Named by the company	85%	2022 to 2026	3

Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Turn Therapeutics Inc's named competitors require a Commercial License.

Unlock Commercial Access

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.